In vitro methods have shown that both animal and human lymphoid cells often have an effective cytotoxicity against autochthonous tumour cells (for a review see Hellstr6m and Hellstrdnm, 1974) . Total or partial block of lymphoid cell mediated immunity, however, may be caused bv serum factors of tumour bearing hosts. 78 immunoglobulin (Hellstr6m and Hellstr6m, 1969) . antigen de- tached from the cell membrane (Sjogren et al., 1971; Currie and Basham, 1972) or complexes consisting of tumour specific antigen-antibody combinations Robins, 1972, 1973; Thomson, Eccles and Alexander, 1973) are thought to be responsible.
Serum factors may thus be determinant elements in the tumour-host relationship. In vivo studies, however, have employed special systems, allogeneic or immunized animals, hyperimmune sera (for a review see Voisin, 1971) , irradiated mice (Vaage,. 1973 ) and spontaneously regressing tumours (Pierce, 1971) . These and other findings (Bansal, Hargreaves and Sj6gren. 1972) Bertini, Forni and Comoglio, 1974) . Six groups of 20 mice were inoculated every 48 h for 30 days with sera or SMA, or both, as shown in the Table. With this inoculation schedule a mean circulating dose of 1 + 0-1 mg/ml SMA was obtained, as determined from the calculation of the half-life of SMA labelled with 3H-acetic anhydride. A similar scheme and the same doses were adopted with ADK-lt.
It can be seen from Fig. 1 that neither tumour take nor growth rate was influenced in any way by repeated injection of MOPC-460 tumour bearer serum or the presence of MOPC-460 SMA in the circulating blood. The result was the same even when the bearer serum and MOPC-460 SMA were administered simultaneously. Figure 2 reveals a similar picture for the ADK-lt experiment. Here the tumour take percentage was reduced to a value of 500, to increase the sensitivity of the system.
Inoculation of treble doses of serum and/or antigen also failed to show differences between the various groups in further experiments using groups of 6 animals and testing both tumours.
DISCUSSION
The results indicate that the preexistence and the passive administration of serum from tumour bearing mice or neoplastic cell membrane solubilized antigens, whether singly or in association, neither enhance nor depress the percentage of takes or the growth rate of two transplantable tumours in previously nonimmunized mice.
The tested tunmours possess tumour specific antigens (Comoglio and Foriii, 1973; Bertini, Forni and Comoglio, 1974) , some of which can be employed to induce resistance (Lynch et al., 1972; Cavallo and Forni, 1974) . Earlier work has also indicated that the "take " of these tumours is influenced by spontaneous or artificially provoked changes in host immune reactivity, suggesting that their growth is hindered by a self-induced mechanism of immunological type . The pre-existence These findings conflict with those obtained in the in vitro system, where sensitized lymphocyte activity is inhibited by soluble factors. Failure of these substances to prove effective in our experiment could be due to employment of doses lying outside some narrow and critical concentration range (Baldwin et al., 1972 (Baldwin et al., , 1973 . Dependence on concentration should, however, be less dominant in vivo since the blocking effect is maintained as the relation between antigen and antibodies varies due to increase in the neoplastic mass. Sub-threshold activity would appear to be excluded by the fact that no differences were observed when the challenge dose was altered, or when administration doses were trebled.
Alternatively, the challenge dose could be sufficient to induce the presence of circulating blocking factors and all-ornothing enhancement of tumour growth. The immunological relation between the host and the developing tumour would thus be unaffected by the administration of further serum factors.
Other explanations may, of course, be forthcoming. Nevertheless, it may fairly be suspected from our findings that serum blocking factors, in spite of their undeniable effect in vitro and certain in vivo contexts, may often fail to produce significant changes in the naturally evolving development of host resistance to tumour growth.
